Wuxi Biologics (Cayman)

Wuxi Biologics (Cayman)

World Rank (Aug-2026)
986
Market Cap (Aug-2026)
26.042 Billion USD
World Rank (Jan-05-2024)
1,181
Market Cap (Jan-05-2024)
14.971 Billion USD
World Rank (Jul-30-2023)
804
Market Cap (Jul-30-2023)
23.456 Billion USD
World Rank (Jan-07-2022)
456
Market Cap (Jan-07-2022)
43.633 Billion USD
World Rank (Jan-01-2021)
296
Market Cap (Jan-01-2021)
54.125 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 83
Headquarters Country
China
Top Technology Companies in China
Top Healthcare Companies in China
Chairman
Ge Li(Non-Executive Chairman)
Employee Count
12,373
Employee Count as of Date
As on 2022
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
3,157 Million USD
Annual Operating Income in USD
1,022 Million USD
Annual Net Income in USD
711 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
9,227 Million USD
Total Liabilities in USD
1,544 Million USD
Total Equity in USD
7,683 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Healthcare Service
Biopharmaceutical
Biotechnology
HealthCare Products
Company Website
WuXi Biologics
Wikipedia
Wikipedia
Yahoo
Yahoo @ Hong Kong
Company Profile

WuXi Biologics is a biotechnology company related to global Contract Research, Development and manufacturing offering end-to-end solutions that enable partners to discover, develop and manufacture biologics.  Headquarters is in China.

Annual Results Summary

WUXI BIOLOGICS (CAYMAN) - Annual Results - Revenue and Net Profit - in Million CNY:

Annual ResultsRevenueNet Income
Dec-202215,2684,420
Dec-202110,2903,388
Dec-20205,6121,688
Dec-20193,9831,013
Dec-20182,534630
Balance Sheet Summary

Total Assets as on Dec-2022 is 49,564 Million CNY.

Total Liabilities as on Dec-2022 is 13,351 Million CNY.

Total Equity as on Dec-2022 is 36,213 Million CNY.

Founded Year
2014
Stock Exchange
HKeX
Frankfurt

Share